Bavarian, that’s not quite correct either. Any application for Fast Track and ODD needs data/evidence that there is some substance to the application. They have yo show they have a realistic chance of treating the disease. It’s not just a simple matter of picking a disease and running with that. As you are well aware they don’t hand out to many of these designations. I think the number was about 230 in the last 12 years. About 20 a year.
The CR and the Stable Disease in a cancer that has no treatment options is what got IMU across the line . Whilst it’s only 2 patients, it’s 2 out of 2 who received a substantial benefit. That’s good data!
IMU Price at posting:
4.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)